What is Tianetin?

TIANEPTIN, also known as stable, coaxil or tatinol, is a prescription drug used to treat depression in all its severity. The drug, which was first synthesized in 1981, is produced and sold by the French pharmaceutical company Servier. Tianetin is primarily sold in countries across Europe, Asia and Latin America. However, the drug is not sold in countries such as the United States, where it has not yet provided it with food and drug approval (FDA). It is a chemical compound so named because it contains three rings of atoms. Like other tricyclic antidepressants, tianeptin blocks reuptake or re -absorption of serotonin. It is a neurotransmitter responsible for a sense of well -being. Retracting then increases the availability of such substances to the brain.R SSRE. It has the opposite way to select serotonin or SSRI inhibitor. While SSRIs are also antidepressants, they more suppress rather than increase serotonin reverse. To anyDory The medical community still cannot find out exactly how the medicine works because some scientists have questioned the SSre theory.

Regardless of the lack of a fixed reason for their effects, tianeptin - sometimes since its initial synthesis by a pair of French scientists named Antoine Deslands and Michael Spedding - used mainly to treat clinical depression. Clinical depression, also known as a major depressive disorder (MDD) or unipolar disorder, refers to cases where people lose a significant degree of self -esteem and interest in their regular daily activities. Tiheptine is also used as an anxiolytic or anti-sound, applied to a wide range of anxiety disorder obsessive compulsive disorder (OCD), social anxiety and even eating disorders such as bulimia. Some scientists theorized that perhaps the neurocentric effects of the drug may lead to drug production in neurodegenerative diseases or STAvů, such as Alzheimer's disease, brain aging and multiple sclerosis.

, regardless of the above option, tianeptin must still be fully seen as a medicine, especially outside their country of origin. Most of the early tianeptin literature was published solely in French, limiting the spread of the knowledge of the drug to the English -speaking world, especially to the United Kingdom and the US, even its developer, Servier, seemed to move his attention from Tianetin to the creation of antidepressant agomelatine, whose brand is Valdoxan. Unlike its predecessor, Valdoxan has a comprehensive patent protection, which is the situation it has gained by the end of 2009.